Biocon Ltd share price logo

Biocon Share Price (BIOCON)

Check the latest share price of Biocon, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹355.70.37%

as on 04:01PM, 30 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

🔔 Supply Milestone Alert

Biocon Biologics has delivered over 100 million insulin cartridges to Malaysia's Ministry of Health, serving over 345,000 patients since 2016.

Biocon Stock Performance

Get live Biocon share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹349.55
    Day's Price Range
    ₹356.6
  • 52 Week's Low

    52 Week's High

    ₹291
    52-Week Price Range
    ₹404.7
1 Month Return+ 5.52 %
3 Month Return+ 4.51 %
1 Year Return-0.91 %
3 Year Return+ 14.92 %
5 Year Return-9.15 %
Previous Close₹354.40
Open₹355.00
Volume26.38L
Upper Circuit₹389.80
Lower Circuit₹319.00

Biocon Fundamentals & Key Indicators

Check Biocon market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹47,381.99 Cr

Return on Equity (ROE)

0.97

PE Ratio (TTM)

41.84

Return on capital employed (ROCE)

2.61

Industry PE ratio

55.58

Beta (LTM)

1.18

P/B Ratio

2.91

Dividend Yield

0.19

PEG Ratio

-523.02

Quarterly Earnings Growth YOY

106.1

EPS (TTM)

10.81

Sector

Pharmaceuticals

Book Value

164.77

Technical Analysis

How to invest in Biocon?

Investing in Biocon is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Biocon or BIOCON on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Biocon or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Biocon with just a few clicks!

Biocon Stock's Interest Amongst Investors

-6.99%

Period Jul 01, 2025 to Jun 01, 2025. Change in 30 Days vs previous period

Investment in Biocon Ltd Shares on INDmoney has dropped by -6.99% over the past 30 days, indicating reduced transactional activity.

37%

Period Jul 01, 2025 to Jun 01, 2025. Change in 30 Days vs previous period

Search interest for Biocon Ltd Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Biocon Valuation

Track how Biocon P/E has moved over time to understand its valuation trends.

Biocon in the last 5 years

  • Overview

  • Trends

Lowest (24.48x)

March 19, 2024

Today (41.84x)

June 27, 2025

Industry (55.58x)

June 27, 2025

Highest (118.86x)

September 27, 2018

LowHigh

Today’s Price to Earnings Ratio: 41.84x

Biocon Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Biocon.

based on 20 analysts

BUY

57.89%

Buy

15.79%

Hold

26.32%

Sell

57.89% of analysts recommend a 'BUY' rating for Biocon. Average target price of ₹377.7

Source: S&P Global Market Intelligence

Biocon Share Price Target

Get share price movements and forecasts by analysts on Biocon.

Biocon price forecast by 20 analysts

Upside of6.57%

High

₹447

Target

₹377.70

Low

₹270

Biocon target price ₹377.7, a slight upside of 6.57% compared to current price of ₹355.7. According to 20 analysts rating.

Source: S&P Global Market Intelligence

Biocon Financial Results

Get the annual and quarterly financial summary of Biocon, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

3864 (0%)3376 (13%)3545 (5%)3773 (6%)4358 (16%)
Net Income

(in ₹ Cr)

223 (0%)862 (287%)27 (97%)81 (199%)459 (466%)
Net Profit Margin5.77% (0%)25.53% (342%)0.76% (97%)2.15% (183%)10.54% (390%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

8623 (0%)8909 (3%)13052 (47%)13798 (6%)
Total Liabilities

(in ₹ Cr)

716 (0%)816 (14%)2136 (162%)2886 (35%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

387 (0%)571 (48%)48 (92%)219 (361%)-123 (156%)

Indices Featuring Biocon Stock

Check stock indices that include Biocon.

Nifty Healthcare

₹14,463.80

0.36 (52.15%)

Nifty Midcap 100

₹59,741.20

0.6 (356.05%)

Nifty LargeMidcap 250

₹16,572.25

0.18 (29.45%)

Nifty MidSmallcap 400

₹20,506.00

0.75 (153%)

Nifty 200

₹14,252.65

-0.16 (-23.4%)

S&P BSE 250 LargeMidCap

₹10,989.62

-0.14 (-15.67%)

Nifty Midcap 150

₹21,988.65

0.68 (148.45%)

BSE Healthcare

₹44,259.41

0.56 (244.71%)

Nifty 500

₹23,617.20

-0.01 (-2.95%)

NIFTY PHARMA

₹22,038.70

0.5 (110.1%)

BSE Mid-Cap

₹46,854.46

0.67 (313.21%)

S&P BSE 150 MidCap

₹16,311.47

0.62 (99.74%)

BSE 500

₹37,043.16

-0.05 (-17.77%)

BSE 200

₹11,592.70

-0.18 (-21.4%)

S&P BSE 400 MidSmallCap

₹12,348.73

0.68 (83.09%)

Biocon Earnings and Dividends

View detailed summary of the earnings and dividend history of Biocon.

  • Biocon Ltd Earnings Results

    Biocon Ltd’s net profit jumped 154.24% since last year same period to ₹344.50Cr in the Q4 2024-2025. On a quarterly growth basis, Biocon Ltd has generated 1272.51% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Biocon Ltd Dividends May,2024

    In the quarter ending March 2024, Biocon Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.56%.

    Read More about Dividends

Biocon Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Biocon.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
54.45%
-10.20
Foreign Institutions
7%
23.66
Mutual Funds
13.82%
57.57
Retail Investors
16.91%
-4.80
Others
7.82%
9.07

Biocon vs Peers

Compare market cap, revenue, PE, and other key metrics of Biocon with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY47,381.99-1.83%0.581,29714,755
HOLD1,76,748.9838.43%0.501,6007,845
BUY1,13,083.0836.35%0.671,65610,727
HOLD29,349.71-0.42%0.507725,664
BUY1,21,350.0226.93%0.505,29127,547

Biocon News & Key Events

Latest news and events in one place to help you make informed investing decisions in Biocon.

  • Biocon Achieves Major Insulin Supply Milestone in Malaysia - 30 Jun, 2025

    Biocon Biologics has surpassed 100 million insulin cartridge deliveries to Malaysia's Ministry of Health, enhancing diabetes care for over 345,000 patients since 2016. This achievement underscores Biocon's commitment to affordable insulin access and strengthens its position in the global insulin market.
  • Biocon Advances with Biosimilar Launch and Debenture Acquisition - 27 Jun, 2025

    Biocon's board approved a $198.5 million debenture acquisition. The company also abandoned weight-loss drug plans in China but received approval for its Eylea biosimilar, Yesafili, launching in Canada on July 4.
  • Biocon Shares Rise Amid Strong Trading Volume - 25 Jun, 2025

    Biocon shares increased by 0.47% to Rs 350.85, driven by high trading volume. The company's financial performance shows significant growth in revenue and net profit, attracting investor interest.
  • Biocon Raises Funds and Partners for Cancer Care - 24 Jun, 2025

    Biocon raised Rs 4,500 crore through QIP to reduce debt and increase its stake in Biocon Biologics. Additionally, it partnered with NCSM to enhance cancer treatment accessibility in Malaysia, aiming to support underserved patients.
  • Biocon Launches QIP to Raise ₹4,500 Crore - 16 Jun, 2025

    Biocon Ltd has initiated a Qualified Institutional Placement (QIP) to raise ₹4,500 crore, setting a floor price of ₹340.20 per share. The funds will be used for debt repayment and growth initiatives.
  • Biocon Ltd Gains for Third Straight Session - 11 Jun, 2025

    Biocon Ltd's stock rose 3.52% to Rs 353.2, marking its third consecutive gain. The stock has increased 4.22% over the past year, outperforming NIFTY and Nifty Pharma index gains. Monthly gains stand at 7.63%, with trading volume significantly above average.
  • Biocon Launches BioWISE Program for Women in STEM - 09 Jun, 2025

    Biocon Foundation, in collaboration with NCBS and BeST Cluster, has launched the BioWISE initiative to support 25 women science students in Karnataka through scholarships and mentorship.
  • Biocon Doubles Insulin Capacity, Sees Growth Ahead - 06 Jun, 2025

    Biocon has doubled its insulin manufacturing capacity in Malaysia, positioning itself as a key player in the market. Chairperson Kiran Mazumdar-Shaw anticipates significant growth in FY26, driven by rising global demand for insulin.
  • Biocon Advances Diabetes Treatment with Key Approvals - 02 Jun, 2025

    Biocon secures CDSCO approval for Liraglutide, a significant diabetes treatment. CEO Kiran Mazumdar Shaw emphasizes Biocon's strategy to dominate the diabesity market and expand its GLP-1 pipeline.

Insights on Biocon Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -16.0 Cr → 344.5 Cr (in ₹), with an average increase of 128.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.66% to 7.00% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.77% to 13.82% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.64K Cr → 4.47K Cr (in ₹), with an average increase of 9.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BIOCON stock has moved up by 5.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 82.3% return, outperforming this stock by 83.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Shree Ganesh Remedies Ltd has given 140.6% return, outperforming this stock by 125.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 17.76% to 16.91% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 60.64% to 54.45% in Jun 2025 quarter

About Biocon

Biocon Ltd is a biopharmaceutical company founded in 1978 by Kiran Mazumdar-Shaw. It is headquartered in Bangalore, India and is one of the top biopharma companies in the world. The company operates in four core areas - biopharmaceuticals, biologics, research services, and clinical research. Biocon's biopharmaceuticals business focuses on biologics and biosimilars, while its biologics business focuses on the discovery, development and commercialization of novel biologics. Its research services include contract research and manufacturing services, while its clinical research business focuses on clinical trials and clinical data management.

Biocon's top products include insulin, monoclonal antibodies, enzymes, and vaccines. Its popular brands include Insugen, Insupen, and Insugen Plus. The company has a strong presence in the Indian market and is expanding its reach to other countries. Biocon has also established its presence in the US, Europe, and Japan.

Revenue: ₹4,358.10Cr as on March 2025 (Q4 FY25)
Net Profit: ₹459.40Cr as on March 2025 (Q4 FY25)
Listing date: 07 Apr, 2004
Chairperson Name: Kiran Mazumdar Shaw
OrganisationBiocon Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEOKiran Mazumdar Shaw
E-voting on sharesClick here to vote

FAQs

What is Biocon share price today?

Biocon share price today stands at ₹355.7, Open: ₹355, Previous Close: ₹354.4, High: ₹356.6, Low: ₹349.55, 52 Week High: ₹404.7, 52 Week Low: ₹291.

What is today's traded volume of Biocon?

Today's traded volume of Biocon is 26.38L. Which means that 26.38L shares of Biocon were bought and sold on the stock market during today's trading session.

What is Biocon's market cap today?

Today's market capitalisation of Biocon is ₹47,381.99 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Biocon?

Biocon’s 52 week high is ₹404.7 and 52 week low is ₹291. The current share price of Biocon is ₹355.7, which is -12.11% down from its 52 week high and 22.23% up from its 52 week low.